Enovix (NASDAQ:ENVX) Stock Price Down 4.5% – What’s Next?

Enovix Co. (NASDAQ:ENVXGet Free Report) shares fell 4.5% on Thursday . The company traded as low as $11.90 and last traded at $11.98. 1,464,205 shares traded hands during mid-day trading, a decline of 73% from the average session volume of 5,452,982 shares. The stock had previously closed at $12.55.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on ENVX shares. Piper Sandler reissued an “overweight” rating and set a $19.00 price objective (down previously from $23.00) on shares of Enovix in a research report on Monday, August 5th. TD Cowen lifted their price target on Enovix from $11.00 to $14.00 and gave the company a “hold” rating in a research note on Thursday, August 1st. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research report on Thursday, August 1st. Benchmark assumed coverage on Enovix in a research report on Monday, July 22nd. They issued a “buy” rating and a $25.00 target price on the stock. Finally, B. Riley raised shares of Enovix to a “strong-buy” rating in a research note on Tuesday, June 25th. One investment analyst has rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $21.33.

Check Out Our Latest Research Report on Enovix

Enovix Price Performance

The business has a fifty day moving average of $9.92 and a 200 day moving average of $10.72. The firm has a market cap of $2.17 billion, a P/E ratio of -9.54 and a beta of 1.98. The company has a quick ratio of 3.84, a current ratio of 3.98 and a debt-to-equity ratio of 0.97.

Enovix (NASDAQ:ENVXGet Free Report) last issued its earnings results on Wednesday, July 31st. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Enovix had a negative return on equity of 91.21% and a negative net margin of 1,434.34%. The company had revenue of $3.77 million during the quarter, compared to the consensus estimate of $3.85 million. On average, sell-side analysts anticipate that Enovix Co. will post -1.21 earnings per share for the current year.

Institutional Investors Weigh In On Enovix

A number of institutional investors have recently made changes to their positions in ENVX. Strong Tower Advisory Services bought a new stake in shares of Enovix in the third quarter valued at about $260,000. Udine Wealth Management Inc. boosted its holdings in Enovix by 15.7% in the 3rd quarter. Udine Wealth Management Inc. now owns 203,484 shares of the company’s stock valued at $1,901,000 after purchasing an additional 27,661 shares during the period. SG Americas Securities LLC grew its position in shares of Enovix by 427.2% during the 3rd quarter. SG Americas Securities LLC now owns 46,989 shares of the company’s stock worth $439,000 after purchasing an additional 38,076 shares in the last quarter. Sanctuary Advisors LLC bought a new position in shares of Enovix during the second quarter worth approximately $1,867,000. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in shares of Enovix in the second quarter valued at approximately $39,000. Institutional investors own 50.92% of the company’s stock.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Articles

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.